A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate Cancer
Public ClinicalTrials.gov record NCT06395753. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Open-Label, Dose-Finding Study of Debio 4228, an Extended-Release Formulation of Gonadotropin-Releasing Hormone Antagonist in Participants With Advanced Prostate Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary purpose of this study is to determine the pharmacokinetics (PK) and pharmacodynamics (PD) of Debio 4228.
Study identification
- NCT ID
- NCT06395753
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 55 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 22, 2024
- Primary completion
- Jun 23, 2026
- Completion
- Jul 21, 2026
- Last update posted
- Aug 23, 2026
2024 – 2026
United States locations
- U.S. sites
- 14
- U.S. states
- 8
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Urologic Surgeons of Arizona | Mesa | Arizona | 85206 | — |
| East Valley Urology Center of Arizona | Queen Creek | Arizona | 85140 | — |
| Bakersfield Institute of Advanced Urology | Bakersfield | California | 93301 | — |
| Grimaldi Urology | Chula Vista | California | 91910 | — |
| Valley Urology | Fresno | California | 93722 | — |
| Tower Urology, | Los Angeles | California | 90048 | — |
| Alarcon Urology Center | Montebello | California | 90640 | — |
| Urology Center of Southern California | Murrieta | California | 92563 | — |
| Biogenix Molecular | Miami | Florida | 33165 | — |
| Icahn School of Medicine at Mount Sinai | New York | New York | 10029 | — |
| Oregon Urology Institut | Springfield | Oregon | 97477 | — |
| Carolina Urologic Research Center | Myrtle Beach | South Carolina | 29572 | — |
| Urology of Virginia | Virginia Beach | Virginia | 23462 | — |
| Summit Cancer Centers of North Spokane | Spokane | Washington | 99208 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06395753, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 23, 2026 · Synced Sep 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06395753 live on ClinicalTrials.gov.